We're crowdfunding! Own a part of our business. Capital at Risk.
View our pitch

Dr Kenny Simmen

Advisory Board

Dr Kenny Simmen

Dr Kenny Simmen, with over 30 years experience within the pharmaceutical industry was, up to recently, part of the Johnson & Johnson Infectious Diseases & Vaccines leadership team. Through his work with Johnson & Johnson Innovation he led the establishment of many international collaborations & license agreements with biotechs and leading academic teams in the US, Europe and Asia.

Dr Simmen was instrumental in driving the antiviral R&D strategy in J&J, and his team advanced multiple candidates into clinical development, including the Hepatitis C virus protease inhibitor (Simeprevir) developed in collaboration with Medivir AB that reached market approval, for which he is also a co-inventor.